RxDoctor Payments Data

Andrea Mitchell

Psychiatric/Mental Health · Milwaukee, WINPI 1346948551

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 409 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,509, 4.0 times the $867 reported in 2023. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,143in general payments, 2019–2025

Across 409 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • Axsome Therapeutics, Inc.$918
  • AbbVie$885
  • Lundbeck LLC$666
  • Vanda Pharmaceuticals Inc.$447
  • Corium, LLC$404
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$6,10499%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,143 in reported general payments places this provider in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olanzapine28$1,503
Lamotrigine71$1,015
Quetiapine Fumarate33$576
Duloxetine Hcl30$506
Bupropion XlBupropion Hcl29$477
Buspirone Hcl29$476
Aripiprazole16$441
Escitalopram Oxalate18$437
Mirtazapine15$404
Clonazepam23$264
Lithium Carbonate21$252
Eszopiclone14$249
Sertraline Hcl62$220
Fluoxetine Hcl45$137
Zolpidem Tartrate12$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$179$22062 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.

Other psychiatric/mental health in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →